NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its fourth quarter revenues rose 11 percent, driven in part by double-digit growth in its molecular diagnostics business.

For the three months ended Sept. 30, the firm reported revenues of $802.9 million up from $726.8 million a year ago, beating the average consensus Wall Street estimate of $792.5 million. On a constant-currency basis, revenues rose 10 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.